Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
1 Response
Leave a Reply
You must be logged in to post a comment.
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
You must be logged in to post a comment.
The ACCLC is a bi-annual event that connects international delegates to learn and share the latest science and technology in anterior eye management and contact lens practice.
Are you sure you want to submit this abstract?
Please confirm your registration:
Dr. Nichols is also an internationally recognized clinician-scientist with long-standing track record of research development, oversight, and scientific discovery. He has over 180 publications and an h-index of 50.
He maintains an ocular surface research group with full scale capabilities for conducting clinical and basic research receiving funding from the National Eye Institute (NEI).
His research unit employs state-of-the art facilities and equipment for the study of dry eye, meibomian gland disease, and pharmaceutical and medical device development and testing.
He has served on numerous medical/advisory boards and boards of directors. His awards include three Ezell Fellowships, the Korb award, the Borish and Max Schapero Awards, the Fry Medal and Westheimer lecturer, and he is a Distinguished Scholar and Fellow of the National Academies of Practice. Lastly, he is editor-in-chief of Contact Lens Spectrum, the world's leading journal on contact lenses.
Professor, Chief Physician of Ophthalmology, Doctoral Supervisor and Director of Department of Refraction and Myopia Control, Zhongshan Ophthalmic Center (ZOC),Sun Yat-Sen University
Prof. Yang is currently the deputy leader of Optometry and Vision Science Group, Ophthalmology Branch, and Chinese Medical Society. Her research interests include orthokeratology, myopia control, and pediatrics ophthalmology. Yang has obtained more than 20 research funds on projects and has been published in professional journals in these fields. Prof. Yang is a fellow of the International Association of Contact lens educators (FIACLE), a fellow of the International Academic Orthokeratology and Myopia Control (FIAOMC ), and the Fellowship Chair, Asia Section of IAOMC.
Dr Thomas Lam completed his undergraduate training with first-class honours in Optometry from PolyU. He was awarded a PhD scholarship to pursue his study on proteomics and animal myopia. He is among the first to pursue global retinal protein profiling and novel protein regulations in the chick myopia model using a mass spectrometry approach. Dr Lam started his academic career in 2008 as a Lecturer in the School of Optometry in PolyU and obtained his first competitive research grant from the RGC in the following year. In 2010, he relocated to Singapore and helped establish the first BSc Optometry degree programme offered by the University of Manchester (UK). He returned to Hong Kong in 2012 and he is currently an Associate Professor of the School of Optometry and serves as Director of PolyU Shenzhen centralized animal facility and Associate Director of PolyU centralized animal facility.
Dr Lam has a good mix of academic and clinical experience. He obtained his fellowship of the American Academy of Optometry (FAAO) in 2009. He has more than 15 years experience in clinical supervision in various optometry clinics locally and overseas. He also actively serves in the profession as an editorial board member of international journals, an organizing committee member of international conferences, a councilor of The Hong Kong Society of Professional Optometrists (HKSPO), and a member of The Optometrists Board of Hong Kong, The Government of the Hong Kong Special Administrative Region. He is currently a PI of Centre for Eye and Vision Research (CEVR), HK Science Park, Research Centre for SHARP Vision, PolyU, Research Centre for Chinese Medicine Innovation (RCMI), PolyU and Shenzhen Research Institute, PolyU.
Lyndon Jones is a Professor at the School of Optometry and Vision Science, University Professor and Director of the Centre for Ocular Research & Education (CORE) at the University of Waterloo. His research interests primarily focus on the interaction of novel and existing contact lens materials with the ocular environment, dry eye and the development of novel materials for ocular drug delivery. He has authored over 500 refereed and professional papers, one text-book and given over 1200 invited lectures at conferences worldwide, in over 40 countries.
Dr Alex Ng is a specialist in Ophthalmology at the Hong Kong Ophthalmic Associates (private practice). His research interests involved cataract surgery, refractive surgery, dry eye disease management and children myopia control. He has over 80 publications in peer-reviewed journals and has delivered over 70 invited talks and instruction courses in both local and international ophthalmology conferences.
He was awarded the Asia Cornea Society Santen Asia Educational Observership Grant Award in 2016, the Distinguished Young Fellow Award of the College of Ophthalmologists of Hong Kong in 2016, the Asia-Pacific Academy of Ophthalmology (APAO) & Singapore Society of Ophthalmology Young Ophthalmologist Award in 2017, the APAO Achievement Award in 2019, and the Japanese Ophthalmological Society (JOS) International Young Investigator Award in 2020. He is also an alumni of the APAO Leadership Development Program (class 2020-21).
Dr Ng currently serves as the honorary secretary at the Hong Kong Ophthalmological Society, editor of the Hong Kong Journal of Ophthalmology, visiting consultant of the Lifeline Express and Associate Ophthalmologist at Orbis.
Noel A. Brennan, MScOptom, PhD, FAAO, is an internationally recognized scientist, author, inventor, and educator. Currently, a research fellow at Johnson & Johnson, he formerly served on the academic staff at the University of Melbourne and was a visiting scholar at Stanford University's Division of Ophthalmology, Department of Surgery, courtesy of a Senior Fulbright scholarship, before directing an eponymous boutique research consulting firm for a number of years. A recognized expert in the field of contact lenses, he now devotes his time to unraveling the mysteries of myopia through optical design, experimentation, data collation, and modeling. He is the designer of the Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management, a named inventor on over 25 US patents, and is coauthor of over 400 papers, including peer-reviewed scientific manuscripts, refereed conference abstracts, educational articles, and industry reports.
About Vision at Johnson & Johnson
Johnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients’ eyes. As a global leader in eye-health, we have a bold ambition: Vision Made Possible – and are paving the way for a new future of eye health to support the full spectrum of pediatric, developed and mature eyes. Through cutting-edge innovation, scientific expertise, and advanced technologies, we are revolutionizing the way people see and experience the world. At every step of the eye health journey – from investigational gene therapies for retinal diseases to contact lenses and refractive and cataract surgical solutions – we stand as a trusted partner with the goal of making vision possible for customers and patients. Visit us at jjvision.com, follow @JNJVision on Twitter, Johnson & Johnson Vision on LinkedIn, and @JNJVision on Facebook.
About CooperVision
CooperVision, a division of CooperCompanies (Nasdaq:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com
Bravo Vision Optical Limited (Distributor of SEED in Hong Kong & Macau)
With a legacy dating back to 1951, SEED embarked on pioneering research in contact lenses. Over the ensuing half-century, we harnessed cutting-edge technologies and fostered unwavering customer trust through our contact lens innovations. Our expertise extends beyond lenses, as we’ve introduced a diverse range of eye-related products to the market. Guided by our corporate philosophy of “Supporting Your Vision with Japanese Quality,” we operate across diversified business domains. As we continue to nurture vision, we remain steadfast in planting "SEED"s in new frontiers, reaping the fruits of our unwavering efforts. Since 2013, Bravo Vision Optical Limited has proudly served as the distributor of SEED in Hong Kong and Macau.
For more information, please visit: https://bv-optical.com/
At Loyal Tech Group, we are constantly striving to improve and expand our product range to meet the evolving needs of our customers. Our aim is to become a trusted partner for ophthalmic professionals by providing top-notch products and unparalleled service.
For more information, please visit: http://www.loyaltech.com.hk/
Headquartered in Singapore, Oculus Private Limited and its group of subsidiaries have over 30 years of experience in manufacturing and supplying high quality contact lens and contact lens care products to eye care practitioners and optical retailers.
Oculus is focused on the innovation, manufacturing and marketing of cosmetic contact lenses and has established FreshKon® as a leading brand of cosmetic contact lens in South East Asia and China. The Oculus group also offers disposable clear contact lenses under FreshKon® brand, specialty contact lens products such as gas permeable lenses under OCUVIQ brand and soft toric contact lenses under Flexcon brand. Oculus’s products are manufactured in accordance to the quality assurance system ISO 13485 requirements and meet the Medical Devices Directive 93/42/EEC.
Oculus has a direct presence in Singapore, China, Hong Kong, Malaysia, Indonesia, and Taiwan, with a network of international distribution partners, Oculus’s products are sold in over 50 countries globally.
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care. Being a truly global company, we work in over 50 countries and serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in Research and Development to meet customer needs and patient demands.
To learn more about Alcon: Alcon Eye Care for Healthcare Professionals | MyAlcon
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.